MARK MALYAK (MD) – Rheumatology Physician, NPI 1659365211
Preparing for Medicare enrollment?
Use our CMS-855 prep checklist: which form applies (855I, 855O, or 855A), readiness score, NPPES field map, and Section 12 documents. Reassignment uses CMS-855I Section 4F—not the discontinued CMS-855R form.
Open Medicare 855 Prep tool →Rheumatology Physician
Main info
Doctor Profile
Contacts
Profile Insights
NPPES metrics only — not quality of care.
Loading map...
Provider Addresses for MARK MALYAK (MD)
200, Spruce Street, Denver, Colorado, 80230, United States
100
DENVER, CO 802307126
Phone: (303) 394-2828
Fax: (303) 320-0242
Type: Mailing
2821 E CEDAR AVE APT 4
DENVER, CO 802093397
Phone: (303) 781-4198
Type: Location
7111 E Lowry Blvd Ste 200
Denver, CO 802307360
Phone: (303) 394-2828
Fax: (303) 320-0242
Type: Location
7111 E LOWRY BLVD STE 200
DENVER, CO 802307360
Phone: (303) 394-2828
Fax: (303) 320-0242
Type: Mailing
NPPES updates history
No NPPES updates recorded for this provider.
Prescription Activity
Loading prescription activity...
Open Payments (CMS)
CMS reports 12 Open Payments records for all available years, with a total value of $175.
Total Amount is formed as General ($175) + Research ($0) + Ownership ($0) = $175.
Last reported payment date: 2024-01-25 • Largest payer in this snapshot: GlaxoSmithKline, LLC. ($158).
Total Amount
$175
General + Research + Ownership
Payments
12
Total payment records
General Amount
$175
General payments
Research Amount
$0
Research funding
Ownership Amount
$0
Ownership interests
Ownership Count
0
Ownership records
Last Payment Date
2024-01-25
Latest reported date
Top Companies
Largest payers in this snapshot
| Company | Amount |
|---|---|
| GlaxoSmithKline, LLC. | $158 |
| ABBVIE INC. | $17 |
Medicare Enrollment & Revalidation
Source: CMS public data · Not endorsed by CMS ·
Educational use only—not medical, billing, or legal advice.
No Medicare enrollment or revalidation data available for this provider in our database.
Prepare CMS-855 application → · Look up this NPI in PECOS → · Verify on CMS PECOS
Medicare Utilization (FFS)
Source: CMS public data · Not endorsed by CMS · Beneficiary counts under 11 are suppressed in source data ·
Educational use only—not medical, billing, or legal advice.
Top Medicare procedures (2023) · refreshed 2026-05-27
| HCPCS | Description | Services | Beneficiaries | Medicare allowed |
|---|---|---|---|---|
| J3262 | Injection, tocilizumab, 1 mg | 61,320 | 15 | $0 |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 14,550 | 33 | $0 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 6,410 | 21 | $0 |
| J0897 | Injection, denosumab, 1 mg | 6,240 | 64 | $0 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 754 | 331 | $0 |
Insurance plans in this area (ZIP 80230)
Loading plans...
Provider's Procedures
| Specialty | Practice State | HCPCS Code | Description | Service Count | Beneficiary Count |
|---|---|---|---|---|---|
| RHEUMATOLOGY | CO | 20610 | Aspiration and/or injection of large joint or joint capsule | 167 | 72 |
| RHEUMATOLOGY | CO | 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 37 | 13 |
| RHEUMATOLOGY | CO | 96415 | Infusion of chemotherapy into a vein | 174 | 33 |
Group practice members
| Name | Specialty | State |
|---|---|---|
| R H E U M A T O L O G Y | CO | |
| R H E U M A T O L O G Y | CO | |
| R H E U M A T O L O G Y | CO | |
| R H E U M A T O L O G Y | CO | |
| R H E U M A T O L O G Y | CO | |
| Rheumatology, Internal Medicine | CO | |
| R H E U M A T O L O G Y | CO | |
| - | CO | |
| - | CO | |
| R H E U M A T O L O G Y | CO |
Reviews
All reviews are moderated before publication. Reviews reflect users' opinions; we do not verify the accuracy of individual reviews.
No reviews yet. Be the first to share your experience — your opinion helps families compare providers.